ArticleCancer biology & therapy2020

Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.

Yang Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.